GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » Price-to-Free-Cash-Flow

BGI Genomics Co (SZSE:300676) Price-to-Free-Cash-Flow : N/A (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co Price-to-Free-Cash-Flow?

As of today (2024-06-06), BGI Genomics Co's share price is ¥37.89. BGI Genomics Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1.90. Hence, BGI Genomics Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for BGI Genomics Co's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 12 years, BGI Genomics Co's highest Price-to-Free-Cash-Flow Ratio was 2695.00. The lowest was 14.16. And the median was 21.89.

SZSE:300676's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.58
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

BGI Genomics Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥-0.45. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥-1.90.

During the past 12 years, BGI Genomics Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 77.80% per year. The lowest was -212.30% per year. And the median was 37.50% per year.


BGI Genomics Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for BGI Genomics Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co Price-to-Free-Cash-Flow Chart

BGI Genomics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 15.55 17.27 - -

BGI Genomics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BGI Genomics Co's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, BGI Genomics Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BGI Genomics Co's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BGI Genomics Co's Price-to-Free-Cash-Flow falls into.



BGI Genomics Co Price-to-Free-Cash-Flow Calculation

BGI Genomics Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=37.89/-1.902
=N/A

BGI Genomics Co's Share Price of today is ¥37.89.
BGI Genomics Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.90.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

BGI Genomics Co  (SZSE:300676) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


BGI Genomics Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


BGI Genomics Co (SZSE:300676) Business Description

Traded in Other Exchanges
N/A
Address
21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.
Executives
Wang Jian Director
Liu Na Executives
Sun Ying Jun Director
Yin Ye Directors, executives
Du Yu Tao Directors, executives
Li Song Gang Supervisors
Hu Yu Jie Supervisors
Xu Qian Secretary Dong
Li Zhi Ping Executives
Chen Yi Qing Executives
Li Wen Qi Supervisors

BGI Genomics Co (SZSE:300676) Headlines

No Headlines